Supply Issues Greiner Bio-One Ltd Safety Blood Collection Sets and Venous Tubes KFK332 and KFK852 (ICN 3264)

• The supply issue with safety blood collection sets and venous tubes from Greiner Bio-One Ltd is now resolved.
• KFK332 and KFK852 are now available to order through our online catalogue.
• This ICN is now closed.

• The supply issue with Safety Blood Collection Sets with Blood Cultures and Venous Tubes from Greiner Bio-One Ltd has improved.
• Three products are now available to order through our online catalogue:
  • KFK221, KFK266 and FNG85017.
• KFK332 and KFK852 remain suspended and unavailable to order.
• Two products are now affected in total.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes.
• The supply issue is now anticipated to be resolved by 13 April 2026.

• The supply issue with Blood Collection Sets and Venous Tubes from Greiner Bio-One Ltd is continuing.
• One further product code is now subject to Protect Demand Management:
  • FNG85017 – Blood Collection Set Safety with Holder 23G.
• One product remains subject to Protect Demand Management:
  • KFK266 – Venous Tube K2 EDTA.
• Three products remain suspended and unavailable to order:
  • KFK332, KFK852 and KFK221.
• Five products are now affected in total.
• KFK266 and FNG85017 are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives and for a full list of product codes subject to Protect Demand Management.
• The supply issue is now anticipated to be resolved by 23 March 2026.

Change:

• The supplier Greiner Bio-One Ltd has informed us of a supply issue with its Safety Blood Collection Sets with Blood Cultures and Venous Tube products.
• There are four product codes affected:
  • KFK332, KFK852, KFK221 and KFK266.
• The supply issue for KFK332, KFK852 is due to increased demand and lead times, and for KFK221 and KFK266 it is due to a labelling error.

Impact:          

• KFK332, KFK852 and KFK221 are suspended and unavailable to order.
• KFK266 is subject to Protect Demand Management.
• KFK266 is available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue.
• However, some of these products may also be subject to intermittent supply.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives and for a full list of product codes subject to Protect Demand Management.
• The supply issue is anticipated to be resolved by 16 March 2026.

Next Steps:               

• Customers are advised to log into our website to view the product listing for further information on the affected product codes and potential alternatives.
• Customers are advised to log into our website to view the product codes currently subject to Protect Demand Management.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.